Author(s): Sheetal Yadav, Sulochana Kaushik, Sunil Kumar Chhikara, Sandeep Singh, Jaya Parkash Yadav, Samander Kaushik

Email(s): samanderkaushik@gmail.com

DOI: 10.52711/0974-360X.2022.00989   

Address: Sheetal Yadav1, Sulochana Kaushik2, Sunil Kumar Chhikara3, Sandeep Singh4, Jaya Parkash Yadav2, Samander Kaushik1*
1Centre for Biotechnology, Maharshi Dayanand University, Rohtak (Hr), India.
2Department of Genetics, Maharshi Dayanand University, Rohtak (Hr), India.
3University Institute of Engineering and Technology (UIET), MDU, Rohtak, India.
4Department of Biochemistry, Maharshi Dayanand University, Rohtak (Hr), India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 12,     Year - 2022


ABSTRACT:
It is believed from ancient times that more than 80-85% of drugs used to treat harmful diseases are obtained from plants. Synthetic medicines are increasing presently, but they have a lot of side effects and are costly. Therefore, people are looking towards medicinal plants. The present review is on Terminalia arjuna, popularly known as the Arjun tree or 'God of Heart' due to its high utility in treating the heart. The morphology, phytochemicals, and biogenic properties of the T. arjuna are explained. It contains tannins, flavonoids, terpenoids secondary metabolites, which show therapeutic potential. T. arjuna has antimutagenic, cardioprotective, hyper-cholesterolaemic, hypolipidemic, anticoagulant, antithrombotic, antiviral, antimalarial, antioxidant, antifungal, and antibacterial properties.


Cite this article:
Sheetal Yadav, Sulochana Kaushik, Sunil Kumar Chhikara, Sandeep Singh, Jaya Parkash Yadav, Samander Kaushik. Terminalia arjuna (Arjun Tree): A Sacred plant with high Medicinal and Therapeutic Potential. Research Journal of Pharmacy and Technology 2022; 15(12):5859-7. doi: 10.52711/0974-360X.2022.00989

Cite(Electronic):
Sheetal Yadav, Sulochana Kaushik, Sunil Kumar Chhikara, Sandeep Singh, Jaya Parkash Yadav, Samander Kaushik. Terminalia arjuna (Arjun Tree): A Sacred plant with high Medicinal and Therapeutic Potential. Research Journal of Pharmacy and Technology 2022; 15(12):5859-7. doi: 10.52711/0974-360X.2022.00989   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-12-83


REFERENCES:
1.    Jain S. Yadav PP. Gill V. Vasudeva N. Singla N. Terminalia arjuna a sacred medicinal plant: phytochemical and pharmacological profile. Phytochemistry Reviews. 2009; 8:491-502. https://doi.org/10.1007/s11101-009-9134-8
2.    Mariyappan M. Bharathidasan R. Mahalingam R. Madhanraj P. Panneerselvam A. Ambikapathy V. Antibacterial Activity of Cardiospermum halicacabum and Melothria heterophylla. Asian Journal of Pharmaceutical Research. 2011;1(4):111-3.
3.    Jeyanthi T. Subramanian P. Kumaravel P. A Comparative Analysis of Antibacterial Activity of Withania somnifera Root Extract with Commercial Antibiotics. Asian Journal Pharmaceutical Research 2013; 3(2): 98-102.
4.    Kumar SS. Melchias G. Ravikumar P. Chandrasekar R. Kumaravel P. Bioinspired synthesis of silver nanoparticles using Euphorbia hirta leaf extracts and their antibacterial activity. Asian Journal of Pharmaceutical Research. 2014;4(1):39-43.
5.    Manvar MN. Antibacterial activity of leaves and flowers of Ipomoea aquatica forsk. (Convolvulacea). Asian Journal of Pharmaceutical Research. 2018;8(2):94-8. 10.5958/2231-5691.2018.00016.3
6.    Das S. Jamal S. Dutta M. Rej S. Chatterjee S. Comparative phytochemical analysis and antimicrobial activity of four medicinal plants. European Journal of Medicinal plants. 2015 Jan 22:191-9. https://www.cabdirect.org/cabdirect/abstract/20153160146
7.    Kaushik S. Dar L. Kaushik S. Kumar R. Kumar D. Yadav JP. In vitro and in silico Anti-dengue activity of Supercritical extract of medicinal plants against Dengue serotype-2. Research Journal of Pharmacy and Technology. 2021; 30;14(11):5895-902. 10.52711/0974-360X.2021.01025
8.    Sharma V. Kaushik S. Pandit P. Dhull D. Yadav JP. Kaushik S. Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Applied Microbiology and Biotechnology. 2019 Jan 18;103(2):881-91. https://doi.org/10.1007/s00253-018-9488-1
9.    Kaushik S. Jangra G. Kundu V. Yadav JP. Kaushik S. Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. Virusdisease. 2020 Sep;31(3):270-6. https://doi.org/10.1007/s13337-020-00584-0
10.    Kaushik S. Dar L. Kaushik S. Yadav JP. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches. Journal of Ethnopharmacology. 2021 Mar 1;267:113541. https://doi.org/10.1016/j.jep.2020.113541
11.    Kaushik S. Kaushik S. Kumar R. Dar L. Yadav JP. In-vitro and in silico activity of Cyamopsis tetragonoloba (Gaur) L. supercritical extract against the dengue-2 virus. VirusDisease. 2020 Dec;31(4):470-8.Pharmacognosy Reviews. 2018 Jul 1;12(24). https://doi.org/10.1007/s13337-020-00624-9
12.    Sharma Y. Kawatra A. Sharma V. Dhull D. Kaushik S. Yadav JP. Kaushik S. In-vitro and in-silico evaluation of the anti-chikungunya potential of Psidium guajava leaf extract and their synthesized silver nanoparticles. VirusDisease. 2021 Apr 11:1-6. https://doi.org/10.1007/s13337-021-00685-4
13.    Muthyala N. A Mini Review Medicinal plants with Antiviral properties against SARS-CoV-2. Research Journal of Pharmacognosy and Phytochemistry. 2021 Jul 1;13(3):158-60.
14.    Kumar S. Garg C. Kaushik S. Buttar HS. Garg M. Demystifying therapeutic potential of medicinal plants against chikungunya virus. Indian Journal of Pharmacology. 2021 Sep;53(5):403. 10.4103/ijp.IJP_81_19
15.    Jagtap NS. Khadabadi SS. Ghorpade DS. Banarase NB. Naphade SS. Antimicrobial and antifungal activity of Centella asiatica (L.) Urban, Umbeliferae. Research Journal of Pharmacy and Technology. 2009;2(2):328-30.
16.    Nitalikar MM. Nitalikar SM. Gunjotikar GA. Aragade PD. Study of antifungal effects of trachyspermum ammi (L.) sprague. Research Journal of Pharmacy and Technology. 2010;3(1):76-8.
17.    Mishra R. Verma DL. Antifungal Activity of Some Rare Himalayan Bryophytes. Research Journal of Pharmacy and Technology. 2011;4(3):474-5.
18.    Kumar R. Nandwani S. Kaushik S. Green synthesized Allium cepa nanoparticles with enhanced antiprotozoal activities for E. gingivalis. Chemical Biology Letters. 2020 Nov 27;7(4):247-50.
19.    Gaikwad D. Jadhav N. A review on biogenic properties of stem bark of Terminalia arjuna : An update. Asian Journal of Pharmaceutical and Clinical Research. 2018; 11:35-39. https://doi.org/10.22159/ajpcr.2018.v11i8.26384
20.    Dar RA. Shahnawaz M. Qazi PH. General overviews of medicinal plants: A review. Journal of Phytopharmacology. 2017; 6:349-351.
21.    Amalraj A. Gopi S. Medicinal properties of Terminalia arjuna (Roxb.) Wight and Arn.: a review. Traditional Journal and Complementary Medicine. 2017; 7:65-78. https://doi.org/10.1016/j.jtcme.2016.02.003
22.    Kumar DS. Prabhakar YS. On the ethnomedical significance of the arjun tree, Terminalia arjuna (Roxb.) Wight and Arnot. Journal of Ethnopharmacology. 1987; 2:173-190. https://doi.org/10.1016/0378-8741(87)90086-9
23.    Ajlan A. Medicinal Plants: A review. Natural Product: An Indian Journal. 2016; 12:1-6.
24.    Bamola N. Verma P. Negi C. A review on some traditional medicinal plants. International Journal Life Scientific Research. 2018; 4:1550-1556. 10.21276/ijlssr.2018.4.1.7
25.    Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry. 2006; 281:87-93. https://doi.org/10.1007/s11010-006-0433-8
26.    Cock IE. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology. 2015; 23:203-229. https://doi.org/10.1007/s10787-015-0246-z
27.    Scassellati S. Forzolini G. Villarini LM. Moretti LM. Marcarelli LM. Pasquini R. et al. Antigenotoxic properties of Terminalia arjuna bark extracts. Journal Environment Pathology Toxicology Oncology: official organ of the Int Soc Environ Toxicol Cancer. 1999; 18:119-125.
28.    Shastry Viswanatha GL. Vaidya SK. Ramesh C. Krishnadas N. Rangappa S. Antioxidant and antimutagenic activities of bark extract of Terminalia arjuna . Asian Pacific Journal Tropical Medicine. 2010; 3:965-970. https://doi.org/10.1016/S1995-7645(11)60010-2
29.    Pandey AK. Mandal AK. Sustainable Harvesting of Terminalia arjuna (Roxb.) Wight & Arnot (Arjuna) and Litsea glutinosa (Lour.) Robinson (Maida) Bark in Central India. Journal of Sustainable Forest. 2012; 31:294-309. https://doi.org/10.1080/10549811.2011.583865
30.    Kaur S. Kumar S. Kaur P. Chandel M. Study of antimutagenic potential of phytoconstituents isolated from Terminalia arjuna in the Salmonella/Microsome Assay. American Journal of Biomedical Sciences. 2010; 2:164-177.
31.    Anka ZM. Singh V. Singh G. Gimba SN. Pharmacological activity of various extracts from Terminalia arjuna Bark. International Journal Current Medical Pharmaceutical Research. 2019; 5:4843-4857.
32.    Gupta N. Jain UK. An update-prominent wound healing property of indigenous medicines. Research Journal of Pharmacy and Technology. 2011; 4:203-213.
33.    Pettit GR. Hoard MS. Doubek DL. Schmidt JM. Pettit RK. Tackett LP. Chapuis JC. Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). Jorunal of Ethnopharmacology. 1996; 53:57-63. https://doi.org/10.1016/S0378-8741(96)01421-3
34.    Boone HA. Medunjanin D. Sijerčić A. Review on potential of phytotherapeutics in fight against COVID-19. Int J Innov Sci Res Technol. 2020; 5:481-491.
35.    Cheng HY. Lin TC. Ishimaru K. Yang CM. Wang KC. Lin CC. In vitro antiviral activity of prodelphinidin B-2 3, 3′-di-O-gallate from Myrica rubra. Planta Medica. 2003; 69:953-956. 10.1055/s-2003-45108
36.    Farwick M. Köhler T. Schild J. Mentel M. Maczkiewitz U. Pagani V. Bonfigli A. et al. Pentacyclic triterpenes from Terminalia arjuna show multiple benefits on aged and dry skin. Skin Pharmacology Physiology. 2014; 27:71-81. https://doi.org/10.1159/000351387
37.    Gupta S. Bisnoi JP. Singh DD. Singh R. Effect of different Drying Technique on the Bioactive Components of Terminalia arjuna Bark. Research Journal of Pharmacy and Technology. 2019; 12:2372-2378.
38.    Gupta S. Bishnoi JP. Kumar N. Kumar H. Nidheesh T. Terminalia arjuna (Roxb.) Wight & Arn.: Competent source of bioactive components in functional food and drugs. Pharmacology Innovation Journal. 2018; 7:223-231.
39.    Chauhan M. Terminalia arjuna properties, benefits, uses and dosage, 2019. Available from: https://www.planetayurveda.com/library/arjuna-terminalia-arjuna/
40.    Priya N. Mathur KC. Sharma A. Agrawal RP. Agarwal V. Acharya J. Effect of Terminalia arjuna on total platelet count and lipid profile in patients of coronary artery disease. Advances in Human Biology. 2019; 9:98-101.
41.    Padma M. Parrakh. Terminalia arjuna (Roxb.) Wt. and Arn.: a review. IJP International Journal of Pharmacology. 2010; 6:515-534.
42.    Soni N. Singh VK. Efficacy and advancement of Terminalia arjuna in Indian Herbal Drug Research: A Review. Trends in Applied Sciences. 2019; 14:233-242. 10.3923/tasr.2019.233.242
43.    Morshed MA. Uddin A. Rahman A. Hasan T. Roy S. Amin AA. et al. In vitro antimicrobial and cytotoxicity screening of Terminalia arjuna ethanol extract. International Journal of Biosciences. 2011; 1:31-38.
44.    Chaudhari UM. Mengi S. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2006; 20:799-805. https://doi.org/10.1002/ptr.1857
45.    Pandey AK. Mandal AK. Sustainable Harvesting of Terminalia arjuna (Roxb.) Wight & Arnot (Arjuna) and Litsea glutinosa (Lour.) Robinson (Maida) Bark in Central India. Journal of Sustainable Forestry. 2012; 31:294-309. https://doi.org/10.1080/10549811.2011.583865
46.    Khan ZH. Faruquee HM. Shaik MM. Phytochemistry and pharmacological potential of Terminalia arjuna L. Medicinal Plant Research. 2013; 3:70-77. 10.5376/mpr.2013.03.0010
47.    Dwivedi S. Udupa N. Terminalia arjuna : pharmacognosy, phytochemistry, pharmacology and clinical use. A review. Fitoterapia. 1989; 60:413-420. https://www.cabdirect.org/cabdirect/abstract/19900394254
48.    Kandil FE. Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. 1998; 47:1567-1568. https://doi.org/10.1016/S0031-9422(97)01078-9
49.    Singh V. Bharadwaj A. Wahi N. Phytochemical analysis and in vitro antimicrobial activities of Terminalia arjuna leaf, bark and fruit extracts in different solvents. Current Trends in Biotechnology and Pharmacy. 2018; 12:286-294.
50.    Moulisha B. Kumar GA. Kanti HP. Anti-leishmanial and anticancer activities of a pentacyclic triterpenoid isolated from the leaves of T. arjuna Combretaceae. Tropical Journal of Pharmaceutical and Research. 2010; 9:135-40. 10.4314/tjpr.v9i2.53700
51.    Singh S. Shukla N. Bhowmick M. Rathi J. Evaluation of Antidiabetic activity of Terminalia arjuna root extract in Alloxan induced diabetic rats. Journal of Biomedical Pharmaceutiacl Research. 2019; 8:20-29.
52.    Patnaik T. Dey RK. Gouda P. Isolation of triterpenoid glycoside from bark of Terminalia arjuna using chromatographic technique and investigation of pharmacological behavior upon muscle tissues. European Journal of Advanced Chemistry Research. 2007; 4:474-479.
53.    Varghese A. Savai J. Pandita N. Gaud R. In vitro modulatory effects of Terminalia arjuna , arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes. Toxicology Reports. 2015; 2:806-816. https://doi.org/10.1016/j.toxrep.2015.02.008
54.    Ahmad MS. Ahmad S. Gautam B. Arshad M. Afzal M. Terminalia arjuna , a herbal remedy against environmental carcinogenicity: an in vitro and in vivo study. Egyptian Journal of Medical Human Genetics. 2014; 15:61-68. https://www.ajol.info/index.php/ejhg/article/view/100847
55.    Wadhai M. Ayate D. Ujjainkar VV. Estimation of tannin content in leaves, bark and fruits of Terminalia arjuna Roxb. International Journal of Farm Sciences. 2019; 9:61-63. 10.5958/2250-0499.2019.00004.1
56.    Verma N. Vinayak M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Molecular Biology Reports. 2009; 36:159-64. https://doi.org/10.1007/s11033-008-9279-3
57.    Hemalatha T. Pulavendran S. Balachandran C. Manohar BM. Puvanakrishnan R. Arjunolic acid: a novel phytomedicine with multifunctional therapeutic applications. Indian J Exp Biol 2010; 48:238-47. http://nopr.niscair.res.in/handle/123456789/7399
58.    Ramesh SA. Christopher GJ. Thankamani V. Comparative Study on Antioxidant Property of Terminalia arjuna Bark and Corewood. Research Journal of Pharmacy and Technology. 2013; 6:996-1000.
59.    Debnath S. Dey D. Hazra S. Ghosh S. Ray R. Hazra B. Antibacterial and antifungal activity of Terminalia arjuna Wight & Arn. bark against multidrug resistant clinical isolates. Journal of Coast Life Medicine. 2013; 1:315-321.
60.    Anand U. Jacobo-Herrera N. Altemimi A. Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019; 9:258. https://doi.org/10.3390/metabo 9110258
61.    Aneja KR. Sharma C. Joshi R. Antimicrobial activity of Terminalia arjuna Wight & Arn.: An ethnomedicinal plant against pathogens causing ear infection. Brazilian Journal of Otorhinolaryngology. 2012; 78:68-74.
62.    Ramya S. Kalaivani T. Rajasekaran C. Jepachanderamohan P. Alaguchamy N. Kalayansundaram M et al. Antimicrobial activity of aqueous extracts of bark, root, leaves and fruits of Terminalia arjuna Wight and Arn. Ethnobotanical leaflets. 2008; 2008:1192-1197. https://opensiuc.lib.siu.edu/ebl/vol2008/iss1/158
63.    Samy RP. Ignacimuthu S. Sen A. Screening of 34 Indian medicinal plants for antibacterial properties. Journal of Ethnopharmacology. 1998; 62:173-181. https://doi.org/10.1016/S0378-8741(98)00057-9
64.    Mandal S. Patra A. Samanta A. Roy S. Mandal A. Mahapatra TD. et al. Analysis of phytochemical profile of Terminalia arjuna bark extract with antioxidative and antimicrobial properties. Asian Pacif Journal of Tropical Biomedicine. 2013; 3:960-966. https://doi.org/10.1016/S2221-1691(13)60186-0
65.    Saivaraj S. Chandramohan G. Antimicrobial activity of natural dyes obtained from Terminalia arjuna (Roxb.) Wight & Arn barks. World Sci News 2018; 98:221-7. https://bibliotekanauki.pl/articles/1177885
66.    Maron DM. Ames BN. Revised methods for Salmonella mutagenicity test. Mut Research/ Environment Mutagenesis and Related Subjects. 1983; 113:173-215. https://doi.org/10.1016/0165-1161(83)90010-9
67.    Kaur SJ. Grover IS. Kumar S. Modulatory effects of a tannin fraction isolated from Terminalia arjuna on the genotoxicity of mutagens in Salmonella typhimurium. Food and Chemical Toxicology. 2000; 38:1113-1119. https://doi.org/10.1016/S0278-6915(00)00104-6
68.    Mythili P. Parameswari CS. Dayana J. Phytochemical analysis of the bark extract of Terminalia arjuna and its cardioprotective effect. Indian Journal of Innovation and Development. 2012; 1:40-42.
69.    Pawar RS. Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna —a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine. 2005; 12:391-393. https://doi.org/10.1016/j.phymed.2003.11.007
70.    Parmar HS. Panda S. Jatwa R. Kar A. Cardio-protective role of T. arjuna bark extract is possibly mediated through alterations in thyroid hormones. Die Pharmazie- Intenational Journal of Pharmaceutical Sciences. 2006; 61:793-795.
71.    Maulik SK. Katiyar CK. Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Current Pharmaceutical Biotechnology. 2010; 11:855-860. https://doi.org/10.2174/138920110793262051
72.    Parveen A. Babbar R. Agarwal S. Kotwani A. Fahim M. Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovascular Toxicology. 2011; 11:48-57. https://doi.org/10.1007/s12012-010-9099-2
73.    Asha S. Taju G. Cardioprotective effect of Terminalia arjuna on caffeine induced coronary heart disease. International Journal of Pharmaceutical and Research. 2012; 3:150-153.
74.    Kumar S. Enjamoori R. Jaiswal A. Ray R. Seth S. Maulik SK. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by T.arjuna (Roxb.). Journal of Pharmacy and Pharmacology. 2009; 61:1529-1536. https://doi.org/10.1211/jpp.61.11.0013
75.    Devi RS. Narayan S. Vani G. Devi CS. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chemico-Biol Interac 2007; 167:71-83. https://doi.org/10.1016/j.cbi.2007.01.011
76.    Devi RS. Narayan S. Vani G. Srinivasan P. Mohan KV. Sabitha KE. Devi CS. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytotherapy Research. 2007; 21:762-767. https://doi.org/10.1002/ptr.2160
77.    Bastin TM. Mani P. Arumugam M. Comparative study on hypoglycemic, hypolipidemic effects of T.arjuna and Murraya koenigii in alloxan-induced diabetic albino rats. Research J. of Pharmacy and Technology. 2011; 4:57-59.
78.    Ragavan B. Krishnakumari S. Antidiabetic effect of T. arjuna bark extract in alloxan induced diabetic rats. Indian Journal of Clinical Biochemistry. 2006; 21(2):123-128. https://doi.org/10.1007/BF02912926
79.    Khaliq F. Fahim M. Role of Terminalia arjuna in improving cardiovascular functions: A review. Indian Journal Physiology Pharmacology. 2018; 62:8-19. https://www.ijpp.com/IJPP%20archives/2018_62_1/8-19.pdf
80.    Gupta S. Bishnoi JP. Phytochemical screening of Terminalia arjuna and Glycyrrhiza glabra showing the effect of different drying techniques. Reseacrh Journal of Pharmacy and Technology. 2019; 12:1566-1568. 10.5958/0974-360X.2019.00259.2
81.    Dwivedi A Firdouse S. Alam P. Tiwari V. Shrivastava V. Evaluation of anthelmintic activity of aqueous and alcoholic extract of bark of Terminalia arjuna W. & A. against earthworm. International Journal of Pharmacy and Life Sciences. 2010; 1:257-259. http://www.ijplsjournal.com/.../3..pdf
82.    Bachaya HA. Iqbal Z. Khan MN. Jabbar A. Gilani AH. Din IU. In vitro and in vivo anthelmintic activity of Terminalia arjuna bark. International Journal of Agriculture and Biology. 2009; 11:273-278. https://doi.org/10.1002/ptr.1800
83.    Ramesh AS. Christopher JG. Radhika R. Setty CR. Thankamani V. Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna . National Product Research. 2012; 26(16): 1549-1552. https://doi.org/10.1080/14786419.2011. 566870
84.    Malik N. Dhawan V. Bahl A. Kaul D. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease. Platelets. 2009; 20:183-190. https://doi.org/10.1080/09537100902809004
85.    Tamilventhan A. Jayaprakash A. Larvicidal Activity of Terminalia arjuna Bark extracts on Dengue Fever Mosquito Ades aegypti. Reseacrh Journal of Pharmacy and Technology. 2019; 12:87-92.https://doi.org/10.1080/14786419.2011.566870

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available